The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity

Nature Structural Biology

Volumn 4, Issue 12, 1997, Pages 1003-1009

  Gillmor, Sarah A ^a   Villaseñor, Armando ^b   Fletterick, Robert ^a,c   Sigal, Elliott ^a,d   Browner, Michelle F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Progenitor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; TRIACYLGLYCEROL LIPASE;

ARTICLE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; LIPOLYSIS; MAMMAL; NONHUMAN; PRIORITY JOURNAL;

MAMMALIA;

EID: 0030736867     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb1297-1003     Document Type: Article

References (43)

1. Samuelsson, B., Dahlén, S.-E., Lingren, J.Å., Rouzer, C.A. & Serhan, C.N. Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects, Science 237, 1171-1176 (1987).
2. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. & Shimizu, T. A G-protein coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620-624 (1997).
3. Devchand, P.R. et al. The PPARa-Leukotriene B4 pathway to inflammation control. Nature 384, 39-43 (1996).
4. Forman, B.M., Chen, J. & Evans, R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Nat. Acad Sci. USA 94, 4312-4317 (1997).
5. Israel, E., Cohn, J., Dubé, L. & Drazen, J.M. Effect of treatment with Zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. J. Am. Med Assn. 275, 931-936 (1996).
6. Shannon, V.R., Stenson, W.F. & Holtzman, M.J. Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease. Am. J. Physiol. 264, G104-111 (1993).
7. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. & Witztum, M.D. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924(1989).
8. Yla-Herttuala, S. et al. Gene expression in macrophage-rich human atherosclerotic lesions, 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest 87, 1146-1152 (1991).
9. Kühn, J., Belkner, J., Zaiss, S., Fahrenklemper, T. & Wohlfeil, S. Involvement of 15-lipoxygenase in early stages of atherosclerosis. J. Exp. Med. 179, 1903-1911 (1994).
10. Ford-Hutchinson, A.W. Arachidonate 15-lipoxygenase; characteristics and potential biological significance. Eicosanoids 4, 65-74 (1991).
11. The CCP4 Suite:Programs for protein crystallography. Acta Crystallogr. D50, 760-763 (1994).
12. Minor, W. et al. Crystal structure of soybean lipoxygenase-1 at 1.4Å resolution. Biochemistry 35, 10687-10701 (1996).
13. Boyington, J.C., Gaffney, B.J. & Amzel, LM. The three-dimensional structure of an arachidonic acid 15-lipoxygenase. Science 260, 1482-1486 (1993).
14. Funk, C.D. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochem. Biophys. Acta 1304, 65-84 (1996).
15. Prigge, S.T., Boyingtoa, J.C., Gaffney, B.J. & Amzel, L.M. Structure conservation in lipoyxgenases: structural analysis of soybean lipoxygenase-1 and modeling of human lipoxygenases. Proteins 24, 275-291 (1996).
16. Sigal, E. et al. Molecular cloning and primary structure of human 15-lipoxygenase. Biochem. Biophys. Res, Comm. 157, 457-464 (1988).
17. Winkler, F.W., D'Arcy, A. & Hunziker, W. Structure of human pancreatic lipase. Nature 343, 771-774 (1990).
18. Williams, S.E. et al. The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor related protein/a2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteinsto LRP. J. Biol. Chem. 269, 8653-8658 (1994).
19. Van Tilbeurgh, H., Sarda, L., Verger, R. & Cambillau, C. Structure of the pancreatic lipase-procolipase complex. Nature 359, 159-163 (1992).
20. Carriere, F. et al. Pancreatic lipase structure-funtion relationships by domain exchange, Biochemstry 36, 239-248 (1997).
21. Miller, D.K. et al. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343, 278-281 (1990).
22. Dixon, R.A.F. et al. Requirement of a 5-lipoxygenase activating protein for leukotriene synthesis. Nature 343, 282-284 (1990).
23. Zhang, Y., Gan, Q.-F., Ravel, E.G., Sigal, E. & Solomon, E.I. EPR definition of the non-heme ferric active sites of mammalian 15-lipoxygenase: major spectral difference relative to human 5-lipoxygenase and plant lipoxygenase and their ligand field origin. J. Am. Chem. Soc 117, 7422-7427 (1995).
24. Gorins, G., Kuhnert, L., Johnson, CR. & Marnett, L.J. (Carboxyalkyl)benzyl propargyl ethers as selective inhibitors of leukocyte-type 12-lipoxygenases. J. Med. Chem. 39, 4871-4878 (1996).
25. Corey, E.J. & Nagata, R. Evidence in favor of an organoiron-mediated pathway for lipoxygenation of fatty acids by soybean lipoxygenase. J Am. Chem. Soc. 109, 8107-8108 (1987).
26. de Groot, J.J. et al. Demonstration by EPR spectroscopy of the functional role of iron in soybean lipoxygenase-1. Biochim. Biophys. Acta 377, 71-79 (1975).
27. Glickman, M.H. & Klinman, J.P. Lipoxygenase reaction mechanism: demonstration that hydrogen abstraction from substrate predeces dioxygen binding during catalytic turnover Biochemistry 35, 12881-12892 (1996).
28. Gan, Q.F., Browner, M.F., Sloane, D.L & Sigal, E. Defining the arachidonic acid binding site of human 15-lipoxygenase. Molecular modeling and mutagenesis. J. Biol. Chem. 271, 25412-25418 (1996).
29. Sloane, D.L, Leung, R., Craik, C.S. & Sigal, E. A primary determinant for lipoxygenase positional specificity. Nature 354, 149-152 (1991).
30. Chen, X.S. & Funk, C.D. Structure-function properties of human platelet 12-lipoxygenase: chimeric enzyme and in vitro mutagenesis studies. Faseb J. 7, 694-701 (1993).
31. Borngräber, S., Kuban, R.-J., Anton, M. & Kühn, H. Phenylalanine 353 is a primary determinant for the positional specificity of Mammalian 15-lipoxygenases. J. Mol Biol. 264, 1145-1153 (1996).
32. Brash, A.R., Boeglin, W.E. & Chang, M.S, Discovery of a second 155-lipoxygenase in humans. Proc Natl. Acad. Sci. USA 94, 6148-6152 (1997).
33. Schewe, T., Rapoport S.M. & Kuhn, H. Enzymology and Physiology of reticulocyte lipoxygenase; comparison with other lipoxygenases. in Advances in enzymology Vol. 58 (ed. Meister, A.) 191-272 (John Wiley and Sons, New York, 1986).
34. Picot, D., Loll, P.J. & Garavito, R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 367, 243-249 (1994).
35. Luong, C. et al. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nature Struct Biol. 3, 927-933 (1996).
36. Li, H. & Poulos, T.L. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate palmitoleic acid. Nature Struct Biol. 4, 140-146 (1997).
37. Sloane, D.L. et al. Purification and crystallization of 15-lipoxygenase from rabbit reticulocytes. Biochem. Biophys. Res. Comm. 173, 507-513 (1990).
38. Otwinowski, Z. Data collection and processing. in Proceedings of the CCP4 Study Weekend: Data Collection and Processing (eds Sawyer, L., Isaacs, N.& Baily, S.) 56-62 (Science and Engineering Research Council, Daresbury Laboratory, Daresbury, England, 1993).
39. Furey, W. & Swamintha, S. PHASES. in Macromolecular crystallography Vol. 276 (eds Carter, C. & Sweet, R.) (Academic Press, Orlando, 1996).
40. Muller, K. MOLOC: A molecular modeling program. Bull. Soc. Chim. 97, 655-667 (1988).
41. Breünger, A.T. X-PLOR: version 3.1 (Yale Press, New Haven, 1987).
42. Holm, L. & Sander, C. Dali ver. 2.0. J. Mol. Biol. 233, 123-138(1993).
43. Nicholls, A., Sharp, K. & Honig, B. Protein folding and association: insights from the interfacical and thermodynamic properties of hydrocarbons. Proteins 11, 281-296 (1991).